world1 outlet covering this

FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection

First publishedMay 22, 17:16 UTC

Last updatedJul 12, 12:31 UTC · 14m ago

↻

each logo = when that outlet publishedlast updated on Braven

Story signals

How strong is this topic?

High significance means broad impact or urgency. Source trust reflects the average authority of outlets covering the story.

Significance5.3

Weighted from impact, urgency, coverage breadth, and topic sensitivity.

Source trust10.0

Average reliability level of outlets included in this topic.

Outlets1

Independent sources contributing to this topic cluster.

More outlets usually means a more confirmed developing story.

The report

Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.

Read the full report at FDA ↗

Related in the knowledge graph

organizationChronic Hepatitis Delta Virus organizationDrug Administration organizationFDA Approves First Treatment organizationHDV organizationHepcludex organizationInfection. Today

Sources (1)

Avg source rating 10.0/10

FDA10